ArticleHaematologica2026

No increased risk of acute myeloid leukemia in adults with primary immune thrombocytopenia treated with thrombopoietin receptor agonists: a French nationwide population-based study.

Yoann Zadro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.